CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 258 filers reported holding CRISPR THERAPEUTICS AG in Q1 2020. The put-call ratio across all filers is 0.73 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $254,364 | -10.0% | 5,654 | +12.3% | 0.00% | 0.0% |
| Q2 2023 | $282,722 | +25.6% | 5,036 | +1.2% | 0.00% | 0.0% |
| Q1 2023 | $225,114 | -44.7% | 4,977 | -20.2% | 0.00% | -60.0% |
| Q3 2022 | $407,000 | +10.0% | 6,235 | +2.5% | 0.01% | +66.7% |
| Q2 2022 | $370,000 | -8.4% | 6,084 | -5.6% | 0.00% | 0.0% |
| Q1 2022 | $404,000 | -53.5% | 6,442 | -43.8% | 0.00% | -57.1% |
| Q4 2021 | $868,000 | -40.1% | 11,457 | -11.5% | 0.01% | -22.2% |
| Q3 2021 | $1,449,000 | -9.2% | 12,942 | +31.3% | 0.01% | -35.7% |
| Q2 2021 | $1,596,000 | +25.9% | 9,859 | -5.2% | 0.01% | +16.7% |
| Q1 2021 | $1,268,000 | +5.8% | 10,404 | +32.8% | 0.01% | 0.0% |
| Q4 2020 | $1,199,000 | +219.7% | 7,832 | +74.6% | 0.01% | +140.0% |
| Q3 2020 | $375,000 | -2.1% | 4,486 | -13.8% | 0.01% | 0.0% |
| Q2 2020 | $383,000 | +85.9% | 5,207 | +7.0% | 0.01% | +25.0% |
| Q1 2020 | $206,000 | -56.1% | 4,867 | -36.8% | 0.00% | -42.9% |
| Q4 2019 | $469,000 | +128.8% | 7,699 | +76.9% | 0.01% | +75.0% |
| Q2 2019 | $205,000 | -44.0% | 4,352 | -47.3% | 0.00% | -50.0% |
| Q3 2018 | $366,000 | +61.2% | 8,260 | +118.8% | 0.01% | +100.0% |
| Q2 2018 | $227,000 | – | 3,775 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 3,608,874 | $160,053,562,000 | 54.44% |
| Abingworth LLP | 1,237,202 | $54,858,000 | 32.62% |
| NEA Management Company, LLC | 2,090,678 | $92,722,000 | 4.00% |
| New Leaf Venture Partners, L.L.C. | 444,708 | $19,723,000 | 3.59% |
| EcoR1 Capital, LLC | 500,000 | $22,175,000 | 2.00% |
| ARK Investment Management | 1,453,590 | $64,467,000 | 1.95% |
| CLOUGH CAPITAL PARTNERS L P | 337,731 | $14,978,000 | 1.41% |
| Casdin Capital, LLC | 220,000 | $9,757,000 | 1.19% |
| Valiant Capital Management, L.P. | 271,700 | $12,050,000 | 1.07% |
| Monashee Investment Management LLC | 110,000 | $4,879,000 | 1.03% |